Envista Holdings Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Envista Holdings Corp 公司

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Envista Holdings Corp簡介



公司代碼NVST

公司名稱Envista Holdings Corp

上市日期Sep 18, 2019

CEOKeel (Paul A)

員工數量12300

證券類型Ordinary Share

年結日Sep 18

公司地址200 S. Kraemer Blvd., Bldg. E

城市BREA

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編92821

電話17148175418

網址https://envistaco.com/en

公司代碼NVST

上市日期Sep 18, 2019

CEOKeel (Paul A)

Envista Holdings Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Paul A. Keel

President, Chief Executive Officer, Director

167.63K

+58.15%

Mr. Stefan Nilsson

President - Nobel Biocare

62.36K

+11.90%

Mr. Mark E. Nance

Senior Vice President, General Counsel, Secretary

56.88K

+9.83%

Ms. Wendy Carruthers

Independent Director

40.16K

-26.02%

Ms. Christine A. Tsingos

Independent Director

40.15K

-26.03%

Mr. Daniel A. Raskas, J.D.

Independent Director

34.23K

-30.53%

Mr. Vivek Jain

Independent Director

33.16K

-31.51%

Ms. Veronica Acurio

President - Orthodontics

11.75K

-381.11%

Mr. Mischa M. Reis

Senior Vice President - Strategy and Corporate Development

--

Mr. R. Scott (Scott) Huennekens

Independent Chairman of the Board

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Paul A. Keel

President, Chief Executive Officer, Director

167.63K

+58.15%

Mr. Stefan Nilsson

President - Nobel Biocare

62.36K

+11.90%

Mr. Mark E. Nance

Senior Vice President, General Counsel, Secretary

56.88K

+9.83%

Ms. Wendy Carruthers

Independent Director

40.16K

-26.02%

Ms. Christine A. Tsingos

Independent Director

40.15K

-26.03%

Mr. Daniel A. Raskas, J.D.

Independent Director

34.23K

-30.53%

收入明細

單位: USD更新時間: 4月6日週一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

1.28B

47.12%

All Other

1.24B

45.74%

China

194.40M

7.15%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 5 小時前

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.63%

Ariel Investments, LLC

7.36%

Dimensional Fund Advisors, L.P.

6.01%

Franklin Mutual Advisers, LLC

4.91%

Vanguard Portfolio Management, LLC

4.65%

其他

68.45%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

8.63%

Ariel Investments, LLC

7.36%

Dimensional Fund Advisors, L.P.

6.01%

Franklin Mutual Advisers, LLC

4.91%

Vanguard Portfolio Management, LLC

4.65%

其他

68.45%

股東類型

持股股東

佔比

Investment Advisor

63.03%

Investment Advisor/Hedge Fund

45.04%

Hedge Fund

11.93%

Pension Fund

1.41%

Sovereign Wealth Fund

1.36%

Research Firm

1.31%

Bank and Trust

0.56%

Individual Investor

0.48%

Private Equity

0.36%

機構持股



更新時間: 4月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2026Q1

711

203.45M

125.03%

-3.29M

2025Q4

698

191.18M

116.72%

-29.60M

2025Q3

713

196.49M

119.50%

-31.47M

2025Q2

735

199.63M

120.11%

-32.52M

2025Q1

767

200.87M

118.49%

-32.33M

2024Q4

774

200.73M

116.58%

-32.33M

2024Q3

769

198.37M

115.33%

-28.47M

2024Q2

775

193.95M

112.83%

-33.23M

2024Q1

793

187.23M

108.93%

-31.14M

2023Q4

800

189.02M

110.25%

-16.86M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

14.04M

8.57%

-276.49K

-1.93%

Dec 31, 2025

Ariel Investments, LLC

11.97M

7.3%

-33.66K

-0.28%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

9.63M

5.88%

+90.59K

+0.95%

Dec 31, 2025

Franklin Mutual Advisers, LLC

7.99M

4.87%

-705.06K

-8.11%

Dec 31, 2025

Atlanta Capital Management Company, L.L.C.

7.38M

4.5%

-1.29M

-14.85%

Dec 31, 2025

Victory Capital Management Inc.

6.06M

3.7%

+146.75K

+2.48%

Dec 31, 2025

AllianceBernstein L.P.

6.04M

3.68%

-62.95K

-1.03%

Dec 31, 2025

Gates Capital Management, Inc.

5.81M

3.54%

-414.85K

-6.67%

Dec 31, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

State Street SPDR S&P Health Care Equipment ETF

1.75%

Schwab Ariel Opportunities ETF

1.51%

Pacer US Export Leaders ETF

0.88%

Distillate Small/Mid Cash Flow ETF

0.58%

Royce Quant Small-Cap Quality Value ETF

0.5%

Harbor Long-Short Equity ETF

0.45%

First Trust Health Care Alphadex Fund

0.41%

iShares U.S. Medical Devices ETF

0.4%

VictoryShares US Small Mid Cap Value Momentum ETF

0.3%

DFA Dimensional US Small Cap Value ETF

0.27%

State Street SPDR S&P Health Care Equipment ETF

佔比1.75%

Schwab Ariel Opportunities ETF

佔比1.51%

Pacer US Export Leaders ETF

佔比0.88%

Distillate Small/Mid Cash Flow ETF

佔比0.58%

Royce Quant Small-Cap Quality Value ETF

佔比0.5%

Harbor Long-Short Equity ETF

佔比0.45%

First Trust Health Care Alphadex Fund

佔比0.41%

iShares U.S. Medical Devices ETF

佔比0.4%

VictoryShares US Small Mid Cap Value Momentum ETF

佔比0.3%

DFA Dimensional US Small Cap Value ETF

佔比0.27%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據